FAILED
首站-论文投稿智能助手
典型文献
Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis
文献摘要:
The neutrophil-to-lymphocyte ratio (NLR) is considered a robust prognostic biomarker for predicting patient survival outcomes in manydiseases. However, it remains unclear whether it can be used as a biomarker for amyotrophic lateral sclerosis (ALS). To correlate NLR with disease progression and survival in sporadic ALS, 1030 patients with ALS between January 2012 and December 2018 were included in this study. These patients were assigned into three groups according to their NLR values: Group 1 (NLR < 2, n = 544 [52.8%]), Group 2 (NLR = 2–3, n = 314 [30.5%]), and Group 3 (NLR > 3, n = 172 [16.7%]). All patients were followed up until April 2020. Patients in Group 3 had a significantly older onset age, a lower score on the Revised ALS Functional Rating Scale, and rapidly progressing disease conditions. Furthermore, faster disease progression rates were associated with higher NLR values (odds ratio = 1.211, 95% confidence interval [CI]: 1.090–1.346, P < 0.001) after adjusting for other risk factors. Compared with Groups 1 and 2, the survival time in Group 3 was significantly shorter (log-rank P = 0.002). The NLR value was considered an independent parameter for the prediction of survival in ALS patients after normalizing for all other potential parameters (hazard ratio [HR] = 1.079, 95% CI: 1.016–1.146, P = 0.014). The effects on ALS survival remained significant when adjusted for treatment (HR = 1.074, 95% CI: 1.012–1.141, Ptrend = 0.019) or when considering the stratified NLR value (HR = 1.115, 95% CI: 1.009–1.232, Ptrend = 0.033). Thus, the NLR may help to predict the rate of disease progression and survival in patients with sporadic ALS. The study was approved by the Institutional Ethics Committee of West China Hospital of Sichuan University, China (approval No. 2015 (236)) on December 23, 2015.
文献关键词:
作者姓名:
Qian-Qian Wei
作者机构:
Department of Neurology,Laboratory of Neurodegenerative Disorders,West China Hospital,Sichuan University,Chengdu,Sichuan Province,China
引用格式:
[1]Qian-Qian Wei-.Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis)[J].中国神经再生研究(英文版),2022(04):875-880
A类:
manydiseases
B类:
Neutrophil,lymphocyte,ratio,sporadic,amyotrophic,lateral,sclerosis,neutrophil,NLR,considered,robust,prognostic,biomarker,predicting,survival,outcomes,However,remains,unclear,whether,used,ALS,To,correlate,progression,patients,between,January,December,were,included,this,study,These,assigned,into,three,groups,according,their,values,All,followed,until,April,Patients,had,significantly,older,onset,age,lower,score,Revised,Functional,Rating,Scale,rapidly,progressing,conditions,Furthermore,faster,rates,associated,higher,odds,confidence,interval,after,adjusting,other,risk,factors,Compared,Groups,was,shorter,log,rank,independent,prediction,normalizing,all,potential,parameters,hazard,effects,remained,when,adjusted,treatment,Ptrend,considering,stratified,Thus,may,help,approved,by,Institutional,Ethics,Committee,West,China,Hospital,Sichuan,University,approval,No
AB值:
0.532191
相似文献
Urinary bladder cancer as a late sequela of traumatic spinal cord injury
Ralf Böthig;Christian Tiburtius;Wolfgang Schöps;Michael Zellner;Oliver Balzer;Birgitt Kowald;Sven Hirschfeld;Roland Thietje;Aki Pietsch;Ines Kurze;Martin Forchert;Thura Kadhum;Klaus Golka-Department of Neuro-Urology,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Urological Practice,53757 Sankt Augustin,Germany;Department of Urology and Neuro-Urology,Johannesbad Fachklinik,94072 Bad Füssing,Germany;Biomechanical Laboratory,Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Centre for Spinal Cord Injuries,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Sports and Rehabilitation Medicine,BG Klinikum Hamburg,21033 Hamburg,Germany;Department of Paraplegiology and Neuro-Urology,Centre for Spinal Cord Injuries,Zentralklinik Bad Berka,99437 Bad Berka,Germany;Staff Position Accident Insurance Law,Statutory Accident Insurance for Wood and Metal(BGHM),33602 Bielefeld,Germany;Department of Psychosomatic Rehabilitation,Mittelrheinklinik Fachklinik,56154 Boppard-Bad Salzig,Germany;Clinical Occupational Medicine,Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund(IfADo),44139 Dortmund,Germany
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression?A systematic review and meta-analysis
Ming-min Xu;Pei Guo;Qing-yu Ma;Xuan Zhou;Yu-long Wei;Lu Wang;Yue Chen;Yu Guo-School of Traditional Chinese Medicine,Jinan University,Guangzhou 510632,Guangdong Province,China;Acupuncture and Tuina School/Third Teaching Hospital,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan Province,China;School of Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan Province,China;Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine,Formula-Pattern Research Center,Jinan University,Guangzhou 510632,Guangdong Province,China;School of Acupuncture-Moxibustion and Tuina,Beijing University of Chinese Medicine,Beijing 100029,China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study
Sun Juxian;Liu Chang;Shi Jie;Wang Nanya;Jiang Dafeng;Mao Feifei;Gu Jingwen;Zhou Liping;Shen Li;Yee Lau Wan;Cheng Shuqun-Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Integrative Oncology, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Outpatient Department, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Oncology, First Hospital of Jilin University, Changchun, Jilin 130000, China;Department of Oncology Zhejiang Sian International Hospital, Jiaxing, Zhejiang 314000, China;Tongji University Cancer Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200040, China;Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。